$PFE News Article - U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults
https://marketwirenews.com/news-releases/u-s-...95358.html